Different model for end-stage liver disease score block distributions may have a variable ability for outcome prediction

Transplantation

Volumn 80, Issue 10, 2005, Pages 1414-1418

  Huo, Teh Ia ^a,b   Lin, Han Chieh ^a,b   Wu, Jaw Ching ^a,b   Lee, Fa Yauh ^a,b   Hou, Ming Chih ^a,b   Lee, Pui Ching ^b   Chang, Full Young ^a,b   Lee, Shou Dong ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Child Turcotte Pugh; Liver cirrhosis; Liver transplantation; MELD

Indexed keywords

ACCURACY; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; FEMALE; HUMAN; INTERMETHOD COMPARISON; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MODEL; MORTALITY; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; ROC CURVE; SCORING SYSTEM; STATISTICAL ANALYSIS;

AGED; FEMALE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 29144520456     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000181164.19658.7a     Document Type: Article

References (30)

1. Annual Report of the US Scientific Registry for Organ Transplantation and the Organ Procurement and Transplantation Network. Transplant Data 1990-1999. UNOS, Richmond, VA, and the Division of Transplantation, Bureau ot Health Resources and Services Administration, US Department of Health and Human Services, Rockville, MD; 2000.
2. Wiesner R, Edwards E, Freeman R, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003; 124:91.
3. Freeman RB Jr., Wiesner RH, Roberts JP, et al. Improving liver allocation: MELD and PELD. Am J Transplant 2004; 4 Suppl 9: 114.
4. Olthoff KM, Brown RS Jr., Delmonico FL, et al. Summary report of a national conference: evolving concepts in liver allocation in the MELD and PELD era. Liver Transpl 2004; 10: A6.
5. Botta F, Giannini E, Romagnoli P, et al. MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study. Gut 2003; 52: 134.
6. Salerno F, Merli M, Cazzaniga M, et al. MELD score is better than Child-Pugh score in predicting 3-month survival of patients undergoing transjugular intrahepatic portosystemic shunt. J Hepatol 2002; 36: 494.
7. Freeman RB. MELD: the holy grail of organ allocation? J Hepatol 2005; 42: 16.
8. Mandell MS. Hepatopulmonary syndrome and portopulmonary hypertension in the model for end-stage liver disease (MELD) era. Liver Transpl 2004; 10 (10 Suppl 2): S54.
9. Heuman DM, Abou-Assi SG, Habib A, et al. Persistent ascites and low serum sodium identity patients with cirrhosis and low MELD scores who are at high risk for early death. Hepatology 2004; 40: 802.
10. Angermayr B, Cejna M, Karnel F, et al. Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt. Gut 2003; 52: 879.
11. Papatheodoridis GV, Cholongitas E, Dimitriadou E, et al. MELD vs Child-Pugh and creatinine-modified Child-Pugh score for predicting survival in patients with decompensated cirrhosis. World J Gastroenterol 2005; 11: 3099.
12. Lucey MR, Brown KA, Everson GT, et al. Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Transplantation 1998; 66: 956.
13. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143: 29.
14. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983; 148: 839.
15. Wang VS, Saab S. Liver transplantation in the era of model for end-stage liver disease. Liver Int 2004; 24: 1.
16. Freeman RB, Wiesner RH, Edwards E, et al. United Network for Organ Sharing Organ Procurement and Transplantation Network Liver and Transplantation Committee. Results of the first year of the new liver allocation plan. Liver Transpl 2004; 10: 7.
17. Said A, Williams J, Holden J, et al. Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease. J Hepatol 2004;40:897.
18. Testa R, Testa E, Giannini E, et al. Trans-catheter arterial chemoembolisation for hepatocellular carcinoma in patients with viral cirrhosis: role of combined staging systems, Cancer Liver Italian Program ( CLIP) and Model for End-stage Liver Disease (MELD), in predicting outcome after treatment. Aliment Pharmacol Ther 2003; 17: 1563.
19. Huo TI, Wu JC, Lin HC, et al. Evaluation of the increase in model for end-stage liver disease (ΔMELD) score over time as a prognostic predictor in patients with advanced liver cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score. J Hepatol 2005; 42: 826.
20. Yoo HY, Edwin D, Thuluvath PI. Relationship of the model for end-stage liver disease (MELD) scale to hepatic encephalopathy, as defined by electroencephalography and neuropsychometric testing, and ascites. Am J Gastroenterol 2003; 98: 1395.
21. Huo TI, Wu JC, Lee SD. MELD in liver transplantation: the da Vinci code for the Holy Grail? J Hepatol 2005; 42: 474.
22. Biggins SW, Rodriguez HI, Bacchetti P, et al. Serum sodium predicts mortality in patients listed for liver transplantation. Hepatology 2004; 41: 32.
23. Ruf AE, Kremers WK, Chavez LL, et al. Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone. Liver Transpl 2005; 11: 336.
24. Merion RM, Schaubel DE, Dykstra DM, et al. The survival benefit of liver transplantation. Am J Transplant 2005; 5: 307.
25. Llovet IM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003; 362: 1907.
26. Maddala YK, Stadheim L, Andrews IC, et al. Drop-out rates of patients with hepatocellular cancer listed for liver transplantation: outcome with chemoembolization. Liver Transpl 2004; 10: 449.
27. Ikeda K, Saitoh S, Koida I, et al. A multivariate analysis of risk factors tor hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology 1993; 18: 47.
28. Van Thiel DH, Yong S, Li SD, et al. The development of de novo hepatocellular carcinoma in patients on a liver transplant list: frequency, size, and assessment of current screening methods. Liver Transpl 2004; 10: 631.
29. Huo TI, Wu IC, Lin HC, et al. Determination of the optimal model for end-stage liver disease (MELD) score in patients with small hepatocellular carcinoma undergoing loco-regional therapy. Liver Transpl 2004; 10: 1507.
30. Onaca NN, Levy MF, Netto GJ, et al. Pretransplant MELD score as a predictor of outcome after liver transplantation for chronic hepatitis C. Am J Transplant 2003; 3: 626.